Generics French drug major Sanofi's (Euronext: SAN) subsidiary Genzyme, which has had supply problems for several of its leading products in recent years, announced that due to the continued progress in its manufacturing operations this year, its supply of Thyrogen (thyrotropin alfa for injection) has been fully restored. As a result, beginning in November, Genzyme is able to supply all patient demand globally. 14 November 2012